Cargando…

Combination treatment with leptin and pioglitazone in a mouse model of Alzheimer's disease

INTRODUCTION: Combination therapy approaches may be necessary to address the many facets of pathologic change in the brain in Alzheimer's disease (AD). The drugs leptin and pioglitazone have previously been shown individually to have neuroprotective and anti-inflammatory actions, respectively,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernandez-Martos, Carmen M., Atkinson, Rachel A.K., Chuah, Meng I., King, Anna E., Vickers, James C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Featured Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651376/ https://www.ncbi.nlm.nih.gov/pubmed/29067321 http://dx.doi.org/10.1016/j.trci.2016.11.002

Ejemplares similares

C9ORF72 expression and cellular localization over mouse development
por: Atkinson, Rachel A K, et al.
Publicado: (2015)

Erratum: C9ORF72 expression and cellular localization over mouse development
por: Atkinson, Rachel A. K., et al.
Publicado: (2016)

Design of Mesoporous Silica Nanoparticles for the Treatment of Amyotrophic Lateral Sclerosis (ALS) with a Therapeutic Cocktail Based on Leptin and Pioglitazone
por: Díaz-García, Diana, et al.
Publicado: (2022)

Severe Early-Onset Obesity Due to Bioinactive Leptin Caused by a p.N103K Mutation in the Leptin Gene
por: Wabitsch, Martin, et al.
Publicado: (2015)

Effects of pioglitazone on mnemonic hippocampal function: A blood oxygen level–dependent functional magnetic resonance imaging study in elderly adults
por: Knodt, Annchen R., et al.
Publicado: (2019)

Environmental novelty exacerbates stress hormones and Aβ pathology in an Alzheimer’s model
por: Stuart, Kimberley E., et al.
Publicado: (2017)

Connectivity of Pathology: The Olfactory System as a Model for Network-Driven Mechanisms of Alzheimer’s Disease Pathogenesis
por: Franks, Katherine H., et al.
Publicado: (2015)

Integrative functional genomic analysis of intron retention in human and mouse brain with Alzheimer's disease
por: Li, Hong‐Dong, et al.
Publicado: (2021)

Reassessment of Pioglitazone for Alzheimer’s Disease
por: Saunders, Ann M., et al.
Publicado: (2021)

Effects of pioglitazone treatment on blood leptin levels in patients with type 2 diabetes
por: Ida, Satoshi, et al.
Publicado: (2017)

Cyclic AC253, a novel amylin receptor antagonist, improves cognitive deficits in a mouse model of Alzheimer's disease
por: Soudy, Rania, et al.
Publicado: (2016)

Defining the Earliest Pathological Changes of Alzheimer’s Disease
por: Vickers, James C., et al.
Publicado: (2016)

Repeat propofol anesthesia does not exacerbate plaque deposition or synapse loss in APP/PS1 Alzheimer’s disease mice
por: Woodhouse, Adele, et al.
Publicado: (2018)

Haloperidol inactivates AMPK and reduces tau phosphorylation in a tau mouse model of Alzheimer's disease
por: Koppel, Jeremy, et al.
Publicado: (2016)

Development of Written Materials for Participants in an Alzheimer's Disease and Related Dementias Screening Trial
por: Head, Katharine J, et al.
Publicado: (2022)

Acute Leptin Treatment Enhances Functional Recovery after Spinal Cord Injury
por: Fernández-Martos, Carmen María, et al.
Publicado: (2012)

Dietary intake of branched-chain amino acids in a mouse model of Alzheimer's disease: Effects on survival, behavior, and neuropathology
por: Tournissac, Marine, et al.
Publicado: (2018)

Combined treatment with memantine and galantamine-CR compared with galantamine-CR only in antidementia drug naïve patients with mild-to-moderate Alzheimer's disease
por: Peters, Oliver, et al.
Publicado: (2015)

An uncommon cold
por: King, Anthony
Publicado: (2020)

Companion coronaviruses
por: King, Anthony
Publicado: (2021)

Altered Brain Leptin and Leptin Receptor Expression in the 5XFAD Mouse Model of Alzheimer’s Disease
por: Pratap, Anishchal A., et al.
Publicado: (2020)

‘I'm institutionalised … there's not much I can do’: Lived experience of housing related delayed discharge
por: Chuah, Christina Pui Ting, et al.
Publicado: (2022)

Gamma rhythm low field magnetic stimulation alleviates neuropathologic changes and rescues memory and cognitive impairments in a mouse model of Alzheimer's disease
por: Zhen, Junli, et al.
Publicado: (2017)

The P522R protective variant of PLCG2 promotes the expression of antigen presentation genes by human microglia in an Alzheimer's disease mouse model
por: Claes, Christel, et al.
Publicado: (2022)

Renal cyst growth is attenuated by a combination treatment of tolvaptan and pioglitazone, while pioglitazone treatment alone is not effective
por: Kanhai, Anish A., et al.
Publicado: (2020)

Telomere length associations with cognition depend on Alzheimer's disease biomarkers
por: Mahoney, Emily R., et al.
Publicado: (2019)

The potential benefit of leptin therapy against amyotrophic lateral sclerosis (ALS)
por: Ferrer‐Donato, Agueda, et al.
Publicado: (2021)

Philosophical Hermeneutics and Teaching Through Behandlung: The Treatment and Handling of Patients With Care
por: Hovey, Richard B, et al.
Publicado: (2020)

Results and insights from a phase I clinical trial of Lomecel‐B for Alzheimer's disease
por: Brody, Mark, et al.
Publicado: (2022)

Synergism of antihypertensives and cholinesterase inhibitors in Alzheimer's disease
por: Hu, Ziheng, et al.
Publicado: (2018)

The costs of developing treatments for Alzheimer's disease: A retrospective exploration
por: Cummings, Jeffrey L., et al.
Publicado: (2021)

Comparative Analysis of Aducanumab, Zagotenemab and Pioglitazone as Targeted Treatment Strategies for Alzheimer’s Disease
por: Abyadeh, Morteza, et al.
Publicado: (2021)

Practical Clinical Guidelines for Natalizumab Treatment in Patients With Relapsing Multiple Sclerosis
por: O'Leary, Shirley, et al.
Publicado: (2023)

Cognitive measures lacking in EHR prior to dementia or Alzheimer's disease diagnosis
por: Maserejian, Nancy, et al.
Publicado: (2021)

Clinical and cognitive characteristics of preclinical Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative cohort
por: Ihara, Ryoko, et al.
Publicado: (2018)

Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum
por: Tosun, Duygu, et al.
Publicado: (2021)

Dissociation of Down syndrome and Alzheimer's disease effects with imaging
por: Matthews, Dawn C., et al.
Publicado: (2016)

Medical Device Regulations for custom-made devices: answers to ten important questions
por: I. J. Green, James
Publicado: (2022)

The prevalence and biomarkers’ characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database
por: Ba, Maowen, et al.
Publicado: (2017)

Two randomized controlled trials of SB742457 in mild-to-moderate Alzheimer's disease
por: Maher-Edwards, Gareth, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_msg192k7556685pkr25f38j51i